no, it will not. because not even the merger is worth that much. heck, it took bioclonetics two years to raise $1.5 mil to do some lab studies. they are several years away from human trials, and i can't find their work peer reviewed by anybody. but, on the front end of this thing, there is not even a guarantee that the loi is will close. and if it does, the new share structure will completely destroy the value of the current shareholder that is buying now. they will have to fully recapitalize the company, which most likely will include a huge r/s, followed by a ton of dilution to raise capital needed to operate. enzc is worth about .0009 right now with 2 billion os it has. and the boiler rooms know it too. good luck here, but what lies ahead is not good for current shareholders based upon the stats of both companies. and that only matters IF the loi even closes, which is not guaranteed. so many people chased this like the merger is completed and they know what the new share structure is going to be. but, neither is true right now. train ride is winding down and in the process of reversing to return to the station.
News 
Market Data 
Discover 
